Search

Your search keyword '"Shinji Hadano"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Shinji Hadano" Remove constraint Author: "Shinji Hadano"
99 results on '"Shinji Hadano"'

Search Results

1. Rare CRHR2 and GRM8 variants identified as candidate factors associated with eating disorders in Japanese patients by whole exome sequencing

2. Personalized Treatment for Infantile Ascending Hereditary Spastic Paralysis Based on In Silico Strategies

3. SQSTM1L341V variant that is linked to sporadic ALS exhibits impaired association with MAP1LC3 in cultured cells

4. Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss

5. Monitoring the autophagy-endolysosomal system using monomeric Keima-fused MAP1LC3B.

6. Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1H46R-expressing ALS mouse model

7. A novel function of N-linked glycoproteins, alpha-2-HS-glycoprotein and hemopexin: Implications for small molecule compound-mediated neuroprotection.

8. Aberration of miRNAs Expression in leukocytes from sporadic amyotrophic lateral sclerosis

9. Dysregulation of the Autophagy-Endolysosomal System in Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases

10. Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.

11. Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking.

12. High-throughput quantitative analysis of axonal transport in cultured neurons from SOD1H46R ALS mice by using a microfluidic device

13. Central nervous system specific high molecular weight ALS2/alsin homophilic complex is enriched in mouse brain synaptosomes

14. The N-terminal intrinsically disordered region mediates intracellular localization and self-oligomerization of ALS2

15. Genetic and clinical characteristics of ALS patients with NEK1 gene variants

16. De-erosion of X chromosome dosage compensation by the editing of

18. Contributors

19. SQSTM1, a protective factor of SOD1-linked motor neuron disease, regulates the accumulation and distribution of ubiquitinated protein aggregates in neuron

20. AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin

21. High-throughput quantitative analysis of axonal transport in cultured neurons from SOD1

22. SQSTM1L341V variant that is linked to sporadic ALS exhibits impaired association with MAP1LC3 in cultured cells

23. Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss

24. Monitoring the autophagy-endolysosomal system using monomeric Keima-fused MAP1LC3B

25. SQSTM1

26. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent

27. Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1H46R-expressing ALS mouse model

28. ALS2, the small GTPase Rab17-interacting protein, regulates maturation and sorting of Rab17-associated endosomes

29. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice

30. Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis

31. Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function

32. Alopecia areata susceptibility variant identified by MHC risk haplotype sequencing reproduces symptomatic patched hair loss in mice

33. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

34. Rostrocaudal Areal Patterning of Human PSC-Derived Cortical Neurons by FGF8 Signaling

35. A novel function of N-linked glycoproteins, alpha-2-HS-glycoprotein and hemopexin: Implications for small molecule compound-mediated neuroprotection

36. An open-type microdevice to improve the quality of fluorescence labeling for axonal transport analysis in neurons

37. Inositol Hexakisphosphate Kinase 2 is a Presymptomatic Biomarker for Amyotrophic Lateral Sclerosis

38. Erratum

39. A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2–ARE pathway: Therapeutic implications for ALS

40. Dysregulation of the Autophagy-Endolysosomal System in Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases

41. Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis

42. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1 transgenic mouse model of ALS

43. Genetic background and gender effects on gross phenotypes in congenic lines of ALS2/alsin-deficient mice

44. Abstracts from the ASENT 2007 Annual Meeting March 5–8, 2007

45. Molecular and cellular function of ALS2/alsin: Implication of membrane dynamics in neuronal development and degeneration

46. The Rab5 Activator ALS2/alsin Acts as a Novel Rac1 Effector through Rac1-activated Endocytosis

47. ALS2CL, a novel ALS2-interactor, modulates ALS2-mediated endosome dynamics

48. A Dopamine D4 Receptor Antagonist Attenuates Ischemia-Induced Neuronal Cell Damage via Upregulation of Neuronal Apoptosis Inhibitory Protein

49. ALS2CL, the novel protein highly homologous to the carboxy-terminal half of ALS2, binds to Rab5 and modulates endosome dynamics

50. Single-nucleotide polymorphisms in uncoding regions of ALS2 gene of Japanese patients with autosomal-recessive amyotrophic lateral sclerosis

Catalog

Books, media, physical & digital resources